AI Summary
This article discusses the discovery and proof of concept of potent dual inhibitors of Polθ and PARP for the treatment of homologous recombination-deficient tumors. The research focuses on developing a more efficient treatment strategy for cancers with DNA repair deficiencies by targeting multiple pathways simultaneously. The outcomes of this research could lead to the development of novel therapies for difficult-to-treat cancers and improve patient outcomes.